It has been reported that the common glucose transporter in humans, GLUT1, is overexpressed in malignancies including hepatic, pancreatic, breast, brain, renal, lung, colorectal, ovarian, and cervical cancers (Yu et al. 2017). The gene discussed is SLC2A1; the disease is cervical cancer.